HeartBeam ROA 2020-2024 | BEAT

Current and historical return on assets (ROA) values for HeartBeam (BEAT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
HeartBeam ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-06-30 $-0.02B $0.01B -111.48%
2024-03-31 $-0.02B $0.01B -82.19%
2023-12-31 $-0.01B $0.02B -93.33%
2023-09-30 $-0.01B $0.02B -119.15%
2023-06-30 $-0.02B $0.02B -176.47%
2023-03-31 $-0.02B $0.00B -290.91%
2022-12-31 $-0.01B $0.00B -164.71%
2022-09-30 $-0.01B $0.01B -109.09%
2022-06-30 $-0.01B $0.01B -94.74%
2022-03-31 $-0.01B $0.01B -85.71%
2021-12-31 $-0.00B $0.01B -106.67%
2021-06-30 $-0.00B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.063B $0.000B
HeartBeam Inc. is a development stage digital healthcare company with proprietary ECG telemedicine technology. HeartBeam Inc. is based in SANTA CLARA, Calif.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $10.500B 0.00
Hims & Hers Health (HIMS) United States $5.733B 148.28
Inspire Medical Systems (INSP) United States $5.716B 178.27
Axonics (AXNX) United States $3.603B 1762.25
IRhythm Technologies (IRTC) United States $2.729B 0.00
Privia Health (PRVA) United States $2.710B 225.80
Enovis (ENOV) United States $2.621B 17.77
Omnicell (OMCL) United States $2.264B 74.08
Azenta (AZTA) United States $2.250B 112.17
10x Genomics (TXG) United States $1.898B 0.00
Schrodinger (SDGR) United States $1.620B 0.00
Clover Health Investments (CLOV) United States $1.617B 0.00
Phreesia (PHR) United States $1.235B 0.00
Standard BioTools (LAB) United States $0.763B 0.00
Fulgent Genetics (FLGT) United States $0.586B 0.00
Butterfly Network (BFLY) United States $0.571B 0.00
Talkspace (TALK) United States $0.569B 0.00
Definitive Healthcare (DH) United States $0.528B 91.40
Health Catalyst (HCAT) United States $0.495B 0.00
Pulmonx (LUNG) United States $0.278B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.261B 0.00
TruBridge (TBRG) United States $0.234B 67.96
P3 Health Partners (PIII) United States $0.140B 0.00
American Well (AMWL) United States $0.136B 0.00
EUDA Health Holdings (EUDA) Singapore $0.098B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
111 (YI) China $0.056B 0.00
CareCloud (CCLD) United States $0.051B 0.00
Zepp Health (ZEPP) China $0.049B 0.00
Outset Medical (OM) United States $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.041B 0.00
Movano (MOVE) United States $0.028B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
MSP Recovery (LIFW) United States $0.017B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00